Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Recruiting 6Completed 6Unknown 5Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Rectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Oropharyngeal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Hypopharyngeal Neoplasms 3Radiation Injuries 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Laryngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neoplasms 1Myelosuppression 1Mouth Neoplasms 1Margins of Excision 1Malignant Tumor of Lacrimal Drainage Structure 1Low Anterior Resection Syndrome 1Locally Advanced Hypopharyngeal Carcinoma 1

Interventions

pembrolizumab 16Radiotherapy 15Paclitaxel 15Drug Therapy 14Cisplatin 13Carboplatin 10Radiation 9Immunotherapy 9Esophagectomy 9Fluorouracil 8Surgical Procedures, Operative 7Capecitabine 7Blood Specimen Collection 7Oxaliplatin 6Nivolumab 6Immune Checkpoint Inhibitors 6Chemoradiotherapy 6nimotuzumab 5Trastuzumab 5130-nm albumin-bound paclitaxel 5sintilimab 4camrelizumab 4Leucovorin 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surveys and Questionnaires 3Endoscopy 3Bevacizumab 3toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Esophageal Neoplasms × Chemoradiotherapy × Clear all
NCT06452602 2026-02-27

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02972372 2025-02-10

CELAEC

The First Affiliated Hospital of Henan University of Science and Technology

Phase NA Recruiting
196 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06429839 2024-05-28

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
55 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06410651 2024-05-13

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
53 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02454790 2024-02-28

SFP OES

University Medical Center Groningen

Recruiting
10,000 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04135664 2019-10-22

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

Shanghai Chest Hospital

Phase 3 Recruiting
176 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡